Jones Financial Companies
JBIO

Jones Financial Companies’s Jade Biosciences JBIO Stock Holding History

Jones Financial Companies’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.94K Buy
270
+268
+13,400% +$5.59K ﹤0.01% 4021
2026
Q1 		$27 Hold
2
– – ﹤0.01% 4685
2025
Q4 		$31 Hold
2
– – ﹤0.01% 4356
2025
Q3 		$17 Hold
2
– – ﹤0.01% 4202
2025
Q2 		$18 Sell
2
-1
-33% -$34 ﹤0.01% 4001
2025
Q1 		$253 Hold
3
– – ﹤0.01% 3573
2024
Q4 		$265 Hold
3
– – ﹤0.01% 3293
2024
Q3 		$206 Hold
3
– – ﹤0.01% 2940
2024
Q2 		$166 Buy
+3
New +$1.99K ﹤0.01% 2386

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jones Financial Companies's JBIO Position: Q2 2026 in Review

Jones Financial Companies increased its Jade Biosciences (JBIO) stake by 13,400% in Q2 2026, buying an estimated $5.59K and bringing the position to 270 shares worth $5.94K. The position accounts for ﹤0.01% of the portfolio, ranked #4021.

Jones Financial Companies first reported a position in JBIO in Q2 2024 and has held it in 9 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Jones Financial Companies held 270 shares of Jade Biosciences worth $5.94K as of Q2 2026.
  • Jones Financial Companies bought 268 Jade Biosciences shares in Q2 2026, an estimated $5.59K.
  • Jade Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4021 holding.
  • Jones Financial Companies first reported a position in Jade Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.